-
My Account
In App
My Account
BSE Live
Dec 12, 16:01Prev. Close
6432.15
Open Price
6371.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 12, 15:57Prev. Close
6430.00
Open Price
6430.00
Bid Price (Qty.)
6426.50 (26)
Offer Price (Qty.)
6427.50 (1)
| Cash Flow of Divis Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 2,916.00 | 2,163.00 | 2,368.63 | 3,683.50 | 2,666.04 | |
| Net CashFlow From Operating Activities | 1,653.00 | 1,261.00 | 2,459.73 | 1,911.80 | 1,946.93 | |
| Net Cash Used In Investing Activities | -804.00 | -269.00 | -2,707.62 | -2,194.92 | 75.13 | |
| Net Cash Used From Financing Activities | -799.00 | -799.00 | -797.17 | -532.44 | -34.89 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 50.00 | 193.00 | -1,045.06 | -815.56 | 1,987.17 | |
| Cash And Cash Equivalents Begin of Year | 363.00 | 170.00 | 1,214.76 | 2,030.32 | 43.15 | |
| Cash And Cash Equivalents End Of Year | 413.00 | 363.00 | 169.70 | 1,214.76 | 2,030.32 |
20.11.2025
Accumulate Divis Laboratories; target of Rs 6795: Deven Choksey
14.11.2025
Divis Labs Consolidated September 2025 Net Sales at Rs 2,715.00 crore, up 16.12% Y-o-Y
12.11.2025
Neutral Divis Laboratories; target of Rs 6925: Motilal Oswal
12.11.2025
Divis Labs Standalone September 2025 Net Sales at Rs 2,660.00 crore, up 15.55% Y-o-Y
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill
